An in vitro study assessed the impact of CBD on colorectal cancer-associated angiogenesis, revealing that CBD inhibited new blood vessel formation by reducing the expression of vascular endothelial growth factor (VEGF) and pro-angiogenic cytokines in tumor cells (35). Here, VEGFA is linked to colorectal cancer.